Identifying novel antibiotics by targeting the EF-Tu complex formation
Identifying novel antibiotics by targeting the EF-Tu complex formation
批准号:
10688951
负责人:
Juan Marugan
金额:
$14.62万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AntibioticsBiological AssayCellsComplexDevelopmentDoseDrug KineticsDrug TargetingElongation FactorEscherichia coliEvaluationFluorescence Resonance Energy TransferFluorescent DyesFutureGram-Negative BacteriaGuanosine TriphosphateHomologous GeneHumanIn VitroLibrariesMycobacterium tuberculosisNational Center for Advancing Translational SciencesNatural ProductsOrganismOutcomePermeabilityPhenylalanine-Specific tRNAProtein BiosynthesisProtocols documentationReaderReagentStreptomycesTestingTransfer RNAWorkanalogbacterial metabolismclinical practicecyanine dye 5inhibitornovelpathogenresponserobotic systemscreeningsmall molecule librariestool
中文摘要
在NCATS,我们启动了在全自动平台qHTS机器人系统上采用1536孔格式建立factumycin、kirromycin和GE2270A的试剂稳定性和剂量响应曲线的检测方案。我们测试了不同的平板阅读器,即Envision、ViewLux和PHERAstar,以确认阅读器特别适用于该分析,看起来Envision是未来平板阅读器的首选。NCATS团队对1280个化合物的LOPAC文库进行了离线和在线两种模式的初步筛选。确定了五个阳性命中。对这些化合物进行二次筛选,以确认筛选结果,发现其中一种化合物具有良好的抗生素活性。目前正在对这一已证实的靶向分子进行药代动力学研究,并对类似物进行评价。
英文摘要
At NCATS, we initiated work on establishing the assay protocol on fully automated platform qHTS robotic system using 1536 well format in terms of reagent stability and dose response curve of factumycin, kirromycin and GE2270A. Different plate readers namely Envision, ViewLux and PHERAstar were tested to confirm the suitability of the reader specifically for this assay and it seems Envision is the plate reader of choice moving forward. Initial screening of LOPAC library of 1280 compounds was performed in offline as well as online mode by NCATS team.Five positive hits were identified. Secondary screening of these compounds, to confirm the screening outcome, disclosed that one of them display good antibiotic activity. Pharmacokinetic studies of this confirmed hit molecule and evaluation of analogues are going.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Kinetic High Throughput Screening for Agonists and Inhibitors of the TRPML1 Ion channel
-
批准号:9770433
-
项目类别:
-
资助金额:$24.51万
-
财政年份:--
-
负责人:Juan Marugan
-
依托单位:
HTS Assay for Identification of Compounds that Reduce PNC Prevalence
-
批准号:9205767
-
项目类别:
-
资助金额:$11.4万
-
财政年份:--
-
负责人:Juan Marugan
-
依托单位:
Small molecule agonists of the relaxin 1 receptor
-
批准号:9359898
-
项目类别:
-
资助金额:$22.7万
-
财政年份:--
-
负责人:Juan Marugan
-
依托单位:
Kinetic High Throughput Screening for Agonists and Inhibitors of the TRPML1 Ion channel
-
批准号:9205759
-
项目类别:
-
资助金额:$11.4万
-
财政年份:--
-
负责人:Juan Marugan
-
依托单位:
Identification of Small Molecule that act on gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome
-
批准号:9205776
-
项目类别:
-
资助金额:$11.4万
-
财政年份:--
-
负责人:Juan Marugan
-
依托单位:
Small molecule agonists of the relaxin 1 receptor
-
批准号:10686739
-
项目类别:
-
资助金额:$42.54万
-
财政年份:--
-
负责人:Juan Marugan
-
依托单位:
A drug based approach for integrin-mediated alleviation for muscular dystrophy
-
批准号:10006285
-
项目类别:
-
资助金额:$25.03万
-
财政年份:--
-
负责人:Juan Marugan
-
依托单位:
Identification of small molecules that decrease the activity of the huntingtin gene promoter for the potential treatment of Huntington Disease
-
批准号:10006272
-
项目类别:
-
资助金额:$13.27万
-
财政年份:--
-
负责人:Juan Marugan
-
依托单位:
Medicinal chemistry campaign to synthesize synaptamide analogs (GPR110)
-
批准号:10006287
-
项目类别:
-
资助金额:$25.03万
-
财政年份:--
-
负责人:Juan Marugan
-
依托单位:
SMN Ubiquitin Ligase
-
批准号:10006283
-
项目类别:
-
资助金额:$25.03万
-
财政年份:--
-
负责人:Juan Marugan
-
依托单位:
Identification of modulators of TRAP1
-
批准号:10006294
-
项目类别:
-
资助金额:$4.08万
-
财政年份:--
-
负责人:Juan Marugan
-
依托单位:
Target validation of CD206 activators
-
批准号:10255303
-
项目类别:
-
资助金额:$11.24万
-
财政年份:--
-
负责人:Juan Marugan
-
依托单位:
High Throughput Screening for Biased Agonists of the TSH Receptor that Activate the Beta-arrestin pathway
-
批准号:10688945
-
项目类别:
-
资助金额:$42.54万
-
财政年份:--
-
负责人:Juan Marugan
-
依托单位:
Identification of small molecule RXFP3 ligands
-
批准号:10688950
-
项目类别:
-
资助金额:$14.62万
-
财政年份:--
-
负责人:Juan Marugan
-
依托单位:
Discovery of Novel Modulators of the Human D2 Dopamine Receptor
-
批准号:10689609
-
项目类别:
-
资助金额:$42.54万
-
财政年份:--
-
负责人:Juan Marugan
-
依托单位:
PAC1 receptor antagonists as potential treatments for depression and atherosclerosis associated with chronic stress
-
批准号:10916021
-
项目类别:
-
资助金额:$31.01万
-
财政年份:--
-
负责人:Juan Marugan
-
依托单位:
Progression of Metarrestin that Reduces PNC Prevalence and Elucidation of its Mechanism of Action
-
批准号:10916028
-
项目类别:
-
资助金额:$31.01万
-
财政年份:--
-
负责人:Juan Marugan
-
依托单位:
Assay for Small-Molecule Antagonists of the TSH Receptor
-
批准号:10916031
-
项目类别:
-
资助金额:$31.01万
-
财政年份:--
-
负责人:Juan Marugan
-
依托单位:
Identifying novel antibiotics by targeting the EF-Tu complex formation
-
批准号:10916040
-
项目类别:
-
资助金额:$12.58万
-
财政年份:--
-
负责人:Juan Marugan
-
依托单位:
Identification Of Small Molecules that Specifically Induce DNA Re-replication in Cancer Cells
-
批准号:9359901
-
项目类别:
-
资助金额:$22.7万
-
财政年份:--
-
负责人:Juan Marugan
-
依托单位:
海外基金